[go: up one dir, main page]

Latest News for: alx

Edit

ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel (Form 8-K) (ALX Oncology Holdings Inc)

Public Technologies 30 Jun 2026
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel ... SOUTH SAN FRANCISCO, Calif., June 30, 2026 - ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq ... About ALX Oncology. ALX Oncology (Nasdaq.
Edit

Material Agreement, Financial Obligation, Termination of Material Agreement (Form 8-K) (ALX Oncology Holdings Inc)

Public Technologies 26 Jun 2026
On June 25, 2026, ALX Oncology Holdings Inc., a Delaware corporation (the "Company"), entered into a loan and security agreement (the "Loan Agreement") ... ALX Oncology Holdings Inc.
Edit

Proxy Results (Form 8-K) (ALX Oncology Holdings Inc)

Public Technologies 11 Jun 2026
). Item 5.07 Submission of matters to a vote of security holders. ALX Oncology Holdings Inc. (the "Company") held its Annual Meeting of stockholders (the "Annual Meeting") on June 10, 2026 ... Proposal 1 ... For ... ALX Oncology Holdings Inc.
Edit

Africa’s talent was never the problem. ALX expands access across the continent

Business Ghana 19 May 2026
By removing constraints of location and schedule, and making access more financially attainable, ALX is opening pathways into the global digital economy ... Entrepreneurs within the ALX community have gone on to create 60,100 jobs.
Edit

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update

Norfolk Daily News 08 May 2026
- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with ... .
Edit

ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update (Form 8-K) (ALX Oncology Holdings Inc)

Public Technologies 08 May 2026
ALX Oncology Reports First Quarter 2026 Financial Results and ... - ALX strengthens leadership team with the appointment of Jeff Knight as Chief Development and Operating Officer - ... ("ALX Oncology" Nasdaq ... About ALX Oncology. ALX Oncology (Nasdaq.
Edit

Investor Presentation ALX Q12026 Earnings (246a15) (ALX Oncology Holdings Inc)

Public Technologies 08 May 2026
© ALX Oncology Inc ... ALX Oncology Q1 202C Results G Business Update ... Chief Executive Officer, ALX Oncology ... Chief Medical Officer, ALX Oncology ... 3 ALX Oncology Corporate Presentation. ALX is Rapidly Advancing Novel, Targeted Cancer Treatments ... ALX Oncology.
Edit

Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) (ALX Oncology Holdings Inc)

Public Technologies 08 May 2026
). Management's Discussion and Analysis of Financial Condition and Results of Operations ... Overview ... Cancer cells leverage CD47, a cell surface protein, as a "don't eat me" signal to evade macrophage phagocytosis ... 2026 ... ALX Oncology Holdings Inc.
Edit

ALX Oncology’s Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced ...

Nasdaq Globe Newswire 07 May 2026
- Data from Phase 1b/2 trial presented at ESMO Breast Cancer 2026 further validate a biomarker-driven development strategy for evorpacept - ... .
Edit

A Waterfront Celebration: ALX Jazz Fest Anchors Alexandria’s 250th Commemoration (City of Alexandria, VA)

Public Technologies 02 May 2026
Celebrate three days of live music at the Alexandria Waterfront as the ALX Jazz Fest expands for its 48th year as part of Sails on the Potomac ... on the Potomac webpage and the ALX Jazz Fest webpage.
Edit

ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026 (ALX Oncology Holdings Inc)

Public Technologies 30 Apr 2026
SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology"; Nasdaq ... About ALX Oncology. ALX Oncology (Nasdaq ... ALX ... ALX Oncology Holdings Inc.
×